A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy (IND# 12697).
Phase of Trial: Phase III
Latest Information Update: 06 May 2017
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Cisplatin; Doxorubicin; Etoposide; Ifosfamide; Methotrexate
- Indications Osteosarcoma
- Focus Therapeutic Use
- Acronyms EURAMOS-1
- 25 Aug 2016 Primary endpoint has not been met. (Event-free survival), as per an article published in the Lancet Oncology.
- 25 Aug 2016 Results published in the Lancet Oncology
- 29 May 2015 Event free survival and overall survival results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.